LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $29,827,000 | -49.7% | 219,803 | +1.7% | 1.76% | -33.0% |
Q3 2018 | $59,318,000 | +35.6% | 216,104 | +2.3% | 2.62% | +16.8% |
Q2 2018 | $43,744,000 | +46.0% | 211,152 | +16.4% | 2.25% | +33.5% |
Q1 2018 | $29,956,000 | +22.9% | 181,378 | +1.9% | 1.68% | +19.4% |
Q4 2017 | $24,379,000 | +8.5% | 178,039 | +7.8% | 1.41% | -1.2% |
Q3 2017 | $22,479,000 | +14.7% | 165,102 | +2.3% | 1.43% | +5.5% |
Q2 2017 | $19,597,000 | +70.1% | 161,422 | +48.3% | 1.35% | +56.4% |
Q1 2017 | $11,522,000 | -35.7% | 108,859 | -38.3% | 0.86% | -44.6% |
Q4 2016 | $17,932,000 | +12.2% | 176,478 | +12.7% | 1.56% | -4.7% |
Q3 2016 | $15,981,000 | +207.9% | 156,585 | +259.8% | 1.64% | +135.7% |
Q2 2016 | $5,191,000 | – | 43,523 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |